Hernandez, Inmaculada

Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries

Hernandez, I., He, M., Brooks, M. M., & Zhang, Y. (2018) · JAMA Network Open

Opioid Use Disorder TreatmentPharmaceutical Practices and Patient Outcomes

Cited by 161

Coverage, Formulary Restrictions, and Out-of-Pocket Costs for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Medicare Part D Program

Luo, J., Feldman, R., Rothenberger, S. D., Hernandez, I., & Gellad, W. F. (2020) · JAMA Network Open

Pharmaceutical Economics and PolicyHealthcare Policy and Management

Cited by 100

Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020

Jacobs, J. A., Addo, D. K., Zheutlin, A. R., Derington, C. G., Essien, U. R., Navar, A. M., Hernandez, I., Lloyd-Jones, D. M., King, J. B., Rao, S., et al. (2023) · JAMA Cardiology

Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular Prevention

Cited by 97

Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular Disease

Luo, J., Feldman, R., Callaway Kim, K., Rothenberger, S., Korytkowski, M., Hernandez, I., & Gellad, W. F. (2023) · JAMA Network Open

Diabetes Treatment and ManagementPharmaceutical Economics and Policy

Cited by 75

A Prescription for Achieving Equitable Access to Antiobesity Medications

Wright, D. R., Guo, J., & Hernandez, I. (2023) · JAMA Health Forum

Pharmacology and Obesity TreatmentObesity and Health Practices

Cited by 42

Medicare Part D Coverage of Anti-obesity Medications: a Call for Forward-Looking Policy Reform

Hernandez, I., Wright, D. R., Guo, J., & Shrank, W. H. (2024) · Journal of General Internal Medicine

Pharmacology and Obesity TreatmentHealthcare Policy and Management

Cited by 18

Using machine learning to identify diabetes patients with canagliflozin prescriptions at high‐risk of lower extremity amputation using real‐world data

Yang, L., Gabriel, N., Hernandez, I., Winterstein, A. G., & Guo, J. (2021) · Pharmacoepidemiology and Drug Safety

Diabetic Foot Ulcer Assessment and ManagementDiabetes Treatment and Management

Cited by 17

2025 AHA/ACC Statement on Cost/Value Methodology in Clinical Practice Guidelines (Update From 2014 Statement)

Kazi, D. S., Abdullah, A. R., Arnold, S. V., Basu, A., Bellows, B. K., Breathett, K., Chew, D. S., Cohen, D. J., DeJong, C., Heidenreich, P. A., et al. (2026) · JACC

Health Systems, Economic Evaluations, Quality of LifeClinical practice guidelines implementation

Cited by 14